BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jänicke RU, Sohn D, Schulze-osthoff K. The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ 2008;15:959-76. [DOI: 10.1038/cdd.2008.33] [Cited by in Crossref: 137] [Cited by in F6Publishing: 116] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc. 2009;84:55-71. [PMID: 19046400 DOI: 10.1111/j.1469-185x.2008.00061.x] [Cited by in Crossref: 273] [Cited by in F6Publishing: 154] [Article Influence: 19.5] [Reference Citation Analysis]
2 Rahman MA, Park MN, Rahman MH, Rashid MM, Islam R, Uddin MJ, Hannan MA, Kim B. p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets. Front Cell Dev Biol 2022;10:761080. [DOI: 10.3389/fcell.2022.761080] [Reference Citation Analysis]
3 Prabhu VV, Allen JE, Hong B, Zhang S, Cheng H, El-Deiry WS. Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opin Ther Targets 2012;16:1161-74. [PMID: 22998602 DOI: 10.1517/14728222.2012.726985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
4 Macher-Goeppinger S, Keith M, Tagscherer KE, Singer S, Winkler J, Hofmann TG, Pahernik S, Duensing S, Hohenfellner M, Kopitz J, Schirmacher P, Roth W. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas. J Pathol 2015;237:460-71. [PMID: 26178300 DOI: 10.1002/path.4592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
5 Shrestha M, Park PH. p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells. Korean J Physiol Pharmacol 2016;20:487-98. [PMID: 27610035 DOI: 10.4196/kjpp.2016.20.5.487] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Song W, Wang J, Yang Y, Jing N, Zhang X, Chen L, Wu J. Rewiring drug-activated p53-regulatory network from suppressing to promoting tumorigenesis. Journal of Molecular Cell Biology 2012;4:197-206. [DOI: 10.1093/jmcb/mjs029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnóczky G, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009;16:1093-107. [PMID: 19373242 DOI: 10.1038/cdd.2009.44] [Cited by in Crossref: 463] [Cited by in F6Publishing: 427] [Article Influence: 35.6] [Reference Citation Analysis]
8 Rudolf J, Raad H, Taieb A, Rezvani HR. NADPH Oxidases and Their Roles in Skin Homeostasis and Carcinogenesis. Antioxidants & Redox Signaling 2018;28:1238-61. [DOI: 10.1089/ars.2017.7282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Yılmaz N, Ozaksit G, Terzi YK, Yılmaz S, Budak B, Aksakal O, Sahin Fİ. HOXA11 and MMP2 gene expression in uterosacral ligaments of women with pelvic organ prolapse. J Turk Ger Gynecol Assoc 2014;15:104-8. [PMID: 24976777 DOI: 10.5152/jtgga.2014.0088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010;20:14-24. [PMID: 19879762 DOI: 10.1016/j.tcb.2009.10.002] [Cited by in Crossref: 218] [Cited by in F6Publishing: 215] [Article Influence: 16.8] [Reference Citation Analysis]
11 Kim D, Park NY, Kang K, Calderwood SK, Cho DH, Bae IJ, Bunch H. Arsenic hexoxide has differential effects on cell proliferation and genome-wide gene expression in human primary mammary epithelial and MCF7 cells. Sci Rep 2021;11:3761. [PMID: 33580144 DOI: 10.1038/s41598-021-82551-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Schmid G, Kramer MP, Węsierska-gądek J. p53-mediated regulation of cell cycle progression: Pronounced impact of cellular microenvironment. J Cell Physiol 2009;219:459-69. [DOI: 10.1002/jcp.21705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Chi RA, van der Watt P, Wei W, Birrer MJ, Leaner VD. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer. BMC Cancer 2021;21:106. [PMID: 33530952 DOI: 10.1186/s12885-021-07819-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu CH, Chen CY, Yeh CT, Lin KH. Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA. Int J Mol Sci 2020;21:E1859. [PMID: 32182776 DOI: 10.3390/ijms21051859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sepúlveda C, Núñez O, Torres A, Guzmán L, Wehinger S. Antitumor Activity of Propolis: Recent Advances in Cellular Perspectives, Animal Models and Possible Applications. Food Reviews International 2020;36:429-55. [DOI: 10.1080/87559129.2019.1649692] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Nam SY, Sabapathy K. p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1. Oncogene 2011;30:4476-86. [PMID: 21552291 DOI: 10.1038/onc.2011.150] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
17 Avery-Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, Talseth-Palmer BA, Rizos H, Zhang XD, Scott RJ. P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation. BMC Cancer. 2011;11:203. [PMID: 21615965 DOI: 10.1186/1471-2407-11-203] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
18 Riger CJ, Fernandes PN, Vilela LF, Mielniczki-Pereira AA, Bonatto D, Henriques JA, Eleutherio EC. Evaluation of heavy metal toxicity in eukaryotes using a simple functional assay. Metallomics 2011;3:1355-61. [PMID: 21879111 DOI: 10.1039/c1mt00086a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Udayakumar T, Shareef MM, Diaz DA, Ahmed MM, Pollack A. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Semin Radiat Oncol 2010;20:258-66. [PMID: 20832018 DOI: 10.1016/j.semradonc.2010.05.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
20 Cheung PY, Deng W, Man C, Tse WW, Srivastava G, Law S, Tsao SW, Cheung AL. Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: implications for carcinogenesis. Cancer Lett 2010;293:41-51. [PMID: 20092939 DOI: 10.1016/j.canlet.2009.12.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
21 Phillips DC, Dias HI, Kitas GD, Griffiths HR. Aberrant Reactive Oxygen and Nitrogen Species Generation in Rheumatoid Arthritis (RA): Causes and Consequences for Immune Function, Cell Survival, and Therapeutic Intervention. Antioxidants & Redox Signaling 2010;12:743-85. [DOI: 10.1089/ars.2009.2607] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.9] [Reference Citation Analysis]
22 Wang Z, Sun Y. Targeting p53 for Novel Anticancer Therapy. Transl Oncol 2010;3:1-12. [PMID: 20165689 DOI: 10.1593/tlo.09250] [Cited by in Crossref: 160] [Cited by in F6Publishing: 142] [Article Influence: 14.5] [Reference Citation Analysis]
23 Sohn D, Graupner V, Neise D, Essmann F, Schulze-osthoff K, Jänicke RU. Pifithrin-α protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ 2009;16:869-78. [DOI: 10.1038/cdd.2009.17] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
24 Taguchi A, Delgado O, Celiktaş M, Katayama H, Wang H, Gazdar AF, Hanash SM. Proteomic signatures associated with p53 mutational status in lung adenocarcinoma. Proteomics 2014;14:2750-9. [PMID: 25331784 DOI: 10.1002/pmic.201400378] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
25 Essmann F, Schulze-Osthoff K. Translational approaches targeting the p53 pathway for anti-cancer therapy. Br J Pharmacol. 2012;165:328-344. [PMID: 21718309 DOI: 10.1111/j.1476-5381.2011.01570.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
26 Gao Z, Chen S, Qin S, Tang C. Network Motifs Capable of Decoding Transcription Factor Dynamics. Sci Rep 2018;8:3594. [PMID: 29483553 DOI: 10.1038/s41598-018-21945-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
27 Pouyet L, Carrier A. Mutant mouse models of oxidative stress. Transgenic Res 2010;19:155-64. [PMID: 19662508 DOI: 10.1007/s11248-009-9308-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
28 Domazet-Loso T, Tautz D. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol 2010;8:66. [PMID: 20492640 DOI: 10.1186/1741-7007-8-66] [Cited by in Crossref: 160] [Cited by in F6Publishing: 141] [Article Influence: 13.3] [Reference Citation Analysis]
29 Kasiappan R, Shih HJ, Wu MH, Choy C, Lin TD, Chen L, Hsu HL. The antagonism between MCT-1 and p53 affects the tumorigenic outcomes. Mol Cancer 2010;9:311. [PMID: 21138557 DOI: 10.1186/1476-4598-9-311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
30 Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle 2013;12:1279-91. [PMID: 23535297 DOI: 10.4161/cc.24364] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
31 Los M, Maddika S, Erb B, Schulze-Osthoff K. Switching Akt: from survival signaling to deadly response. Bioessays 2009;31:492-5. [PMID: 19319914 DOI: 10.1002/bies.200900005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
32 Yokouchi H, Nishihara H, Harada T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Nishimura M, Suzuki H, Dosaka-Akita H, Isobe H. Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival. Heliyon 2020;6:e04439. [PMID: 32685741 DOI: 10.1016/j.heliyon.2020.e04439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Goud ESK, Pandey M, Singh C, Vedamurthy GV, Singh D, Onteru SK. Effect of Dioxins in Milk on the 3D Cultured Primary Buffalo Hepatocyte Model System. J Agric Food Chem 2019;67:8007-19. [PMID: 31268702 DOI: 10.1021/acs.jafc.9b03384] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Lampichler K, Ferrer P, Vila G, Lutz MI, Wolf F, Knosp E, Wagner L, Luger A, Baumgartner-Parzer S. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation. Endocr Relat Cancer 2015;22:793-803. [PMID: 26219678 DOI: 10.1530/ERC-15-0109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Gogna R, Madan E, Khan M, Pati U, Kuppusamy P. p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. EMBO Mol Med 2013;5:1662-83. [PMID: 24096875 DOI: 10.1002/emmm.201202055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
36 Węsierska-Gądek J, Walzi E, Dolečkova I, Schmid G. Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme. Cancer Microenviron 2009;2:215-25. [PMID: 19731086 DOI: 10.1007/s12307-009-0024-9] [Reference Citation Analysis]
37 Dyshlovoy SA, Madanchi R, Hauschild J, Otte K, Alsdorf WH, Schumacher U, Kalinin VI, Silchenko AS, Avilov SA, Honecker F, Stonik VA, Bokemeyer C, von Amsberg G. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells. BMC Cancer 2017;17:93. [PMID: 28143426 DOI: 10.1186/s12885-017-3085-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
38 Tian XJ, Liu F, Zhang XP, Li J, Wang W. A two-step mechanism for cell fate decision by coordination of nuclear and mitochondrial p53 activities. PLoS One 2012;7:e38164. [PMID: 22679490 DOI: 10.1371/journal.pone.0038164] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
39 Ring A, Kaur P, Lang JE. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. BMC Cancer 2020;20:1076. [PMID: 33167919 DOI: 10.1186/s12885-020-07573-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Murray D, Mirzayans R, McBride WH. Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity. Radiat Res 2018;190:331-49. [PMID: 30040046 DOI: 10.1667/RR15101.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
41 Jung H, Kim MJ, Kim DO, Kim WS, Yoon SJ, Park YJ, Yoon SR, Kim TD, Suh HW, Yun S, Min JK, Lee HG, Lee YH, Na HJ, Lee DC, Kim HC, Choi I. TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress. Cell Metab 2013;18:75-85. [PMID: 23823478 DOI: 10.1016/j.cmet.2013.06.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
42 Conti A, Rodriguez GC, Chiechi A, Blazquez RM, Barbado V, Krènacs T, Novello C, Pazzaglia L, Quattrini I, Zanella L, Picci P, De Alava E, Benassi MS. Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 2011;178:88-97. [PMID: 21224047 DOI: 10.1016/j.ajpath.2010.11.035] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
43 Chobotova K. Aging and cancer: converging routes to disease prevention. Integr Cancer Ther 2009;8:115-22. [PMID: 19679619 DOI: 10.1177/1534735409335505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
44 Pang J, Maienschein-Cline M, Koh TJ. Reduced apoptosis of monocytes and macrophages is associated with their persistence in wounds of diabetic mice. Cytokine 2021;142:155516. [PMID: 33810946 DOI: 10.1016/j.cyto.2021.155516] [Reference Citation Analysis]
45 Italiano D, Lena AM, Melino G, Candi E. Identification of NCF2/p67phox as a novel p53 target gene. Cell Cycle 2012;11:4589-96. [PMID: 23187810 DOI: 10.4161/cc.22853] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
46 Liao Z, Yeo HL, Wong SW, Zhao Y. Cellular Senescence: Mechanisms and Therapeutic Potential. Biomedicines 2021;9:1769. [PMID: 34944585 DOI: 10.3390/biomedicines9121769] [Reference Citation Analysis]
47 Kamp DW. Asbestos-induced lung diseases: an update. Transl Res 2009;153:143-52. [PMID: 19304273 DOI: 10.1016/j.trsl.2009.01.004] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 11.9] [Reference Citation Analysis]
48 El-Sahar AE, Rastanawi AA, El-Yamany MF, Saad MA. Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis. Life Sci 2020;257:118076. [PMID: 32659371 DOI: 10.1016/j.lfs.2020.118076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
49 Lee K, Gusella GL, He JC. Epithelial proliferation and cell cycle dysregulation in kidney injury and disease. Kidney Int 2021;100:67-78. [PMID: 33831367 DOI: 10.1016/j.kint.2021.03.024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Carter BZ, Mak DH, Schober WD, Koller E, Pinilla C, Vassilev LT, Reed JC, Andreeff M. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML. Blood. 2010;115:306-314. [PMID: 19897582 DOI: 10.1182/blood-2009-03-212563] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
51 Furth N, Bossel Ben-Moshe N, Pozniak Y, Porat Z, Geiger T, Domany E, Aylon Y, Oren M. Down-regulation of LATS kinases alters p53 to promote cell migration. Genes Dev 2015;29:2325-30. [PMID: 26588988 DOI: 10.1101/gad.268185.115] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
52 Batista LFZ, Kaina B, Meneghini R, Menck CFM. How DNA lesions are turned into powerful killing structures: insights from UV-induced apoptosis. Mutat Res 2009;681:197-208. [PMID: 18845270 DOI: 10.1016/j.mrrev.2008.09.001] [Cited by in Crossref: 123] [Cited by in F6Publishing: 114] [Article Influence: 8.8] [Reference Citation Analysis]
53 Volcic M, Karl S, Baumann B, Salles D, Daniel P, Fulda S, Wiesmüller L. NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes. Nucleic Acids Res 2012;40:181-95. [PMID: 21908405 DOI: 10.1093/nar/gkr687] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
54 Nagano T, Awai Y, Kuwaba S, Osumi T, Mio K, Iwasaki T, Kamada S. Riboflavin transporter SLC52A1, a target of p53, suppresses cellular senescence by activating mitochondrial complex II. Mol Biol Cell 2021;32:br10. [PMID: 34524871 DOI: 10.1091/mbc.E21-05-0262] [Reference Citation Analysis]
55 Takahashi S, Shirahama K. Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells. Biomed Rep 2016;4:83-6. [PMID: 26870340 DOI: 10.3892/br.2015.541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Cheng Z, Tang Y, Chen Y, Kim S, Liu H, Li SS, Gu W, Zhao Y. Molecular characterization of propionyllysines in non-histone proteins. Mol Cell Proteomics 2009;8:45-52. [PMID: 18753126 DOI: 10.1074/mcp.M800224-MCP200] [Cited by in Crossref: 108] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
57 Khan H, Reale M, Ullah H, Sureda A, Tejada S, Wang Y, Zhang ZJ, Xiao J. Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions. Biotechnol Adv 2020;38:107385. [PMID: 31004736 DOI: 10.1016/j.biotechadv.2019.04.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
58 Badr CE, Van Hoppe S, Dumbuya H, Tjon-Kon-Fat LA, Tannous BA. Targeting cancer cells with the natural compound obtusaquinone. J Natl Cancer Inst 2013;105:643-53. [PMID: 23479453 DOI: 10.1093/jnci/djt037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
59 Huang CC, Chou CH, Yang YS, Ho HN, Shun CT, Wen WF, Chen SU, Chen MJ. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy. Mol Hum Reprod 2021;27:gaaa084. [PMID: 33543290 DOI: 10.1093/molehr/gaaa084] [Reference Citation Analysis]
60 Gudkov AV, Komarova EA. p53 and the Carcinogenicity of Chronic Inflammation. Cold Spring Harb Perspect Med 2016;6:a026161. [PMID: 27549311 DOI: 10.1101/cshperspect.a026161] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
61 Pardee TS, Zuber J, Lowe SW. Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner. Exp Hematol 2011;39:473-485.e4. [PMID: 21288478 DOI: 10.1016/j.exphem.2011.01.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
62 Mandinova A, Lee SW. The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med 2011;3:64rv1. [PMID: 21209413 DOI: 10.1126/scitranslmed.3001366] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
63 Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev 2011;14:179-245. [PMID: 21534089 DOI: 10.1080/10937404.2011.556051] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 8.5] [Reference Citation Analysis]
64 Aylon Y, Oren M. The Paradox of p53: What, How, and Why? Cold Spring Harb Perspect Med 2016;6:a026328. [PMID: 27413116 DOI: 10.1101/cshperspect.a026328] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
65 Nichterwitz S, Nijssen J, Storvall H, Schweingruber C, Comley LH, Allodi I, Lee MV, Deng Q, Sandberg R, Hedlund E. LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy. Genome Res 2020;30:1083-96. [PMID: 32820007 DOI: 10.1101/gr.265017.120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
66 Sen T, Sen N, Huang Y, Sinha D, Luo ZG, Ratovitski EA, Sidransky D. Tumor protein p63/nuclear factor κB feedback loop in regulation of cell death. J Biol Chem 2011;286:43204-13. [PMID: 22020940 DOI: 10.1074/jbc.M111.257105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
67 Okubo T, Saito T, Mitomi H, Takagi T, Torigoe T, Suehara Y, Kaneko K, Yao T. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1. Virchows Arch 2013;463:67-77. [PMID: 23748877 DOI: 10.1007/s00428-013-1435-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
68 Neilsen PM, Noll JE, Suetani RJ, Schulz RB, Al-Ejeh F, Evdokiou A, Lane DP, Callen DF. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2011;2:1203-17. [PMID: 22203497 DOI: 10.18632/oncotarget.382] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 8.4] [Reference Citation Analysis]
69 Briest F, Grabowski P. The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms. Cancer Treat Rev 2015;41:423-30. [PMID: 25837868 DOI: 10.1016/j.ctrv.2015.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
70 Mirzayans R, Andrais B, Kumar P, Murray D. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome. Int J Mol Sci 2017;18:E928. [PMID: 28452953 DOI: 10.3390/ijms18050928] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
71 Wang Z, Zheng M, Li Z, Li R, Jia L, Xiong X, Southall N, Wang S, Xia M, Austin CP, Zheng W, Xie Z, Sun Y. Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res 2009;69:6556-64. [PMID: 19679550 DOI: 10.1158/0008-5472.CAN-09-0891] [Cited by in Crossref: 73] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
72 Vilborg A, Bersani C, Wilhelm MT, Wiman KG. The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? Cell Death Differ 2011;18:1434-40. [PMID: 21394102 DOI: 10.1038/cdd.2011.20] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
73 Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2011;30:1082-1097. [PMID: 21057537 DOI: 10.1038/onc.2010.487] [Cited by in Crossref: 246] [Cited by in F6Publishing: 238] [Article Influence: 20.5] [Reference Citation Analysis]
74 Shin HJ, Kwon HK, Lee JH, Gui X, Achek A, Kim JH, Choi S. Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53. Sci Rep 2015;5:15798. [PMID: 26522181 DOI: 10.1038/srep15798] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
75 Amaral JD, Castro RE, Steer CJ, Rodrigues CM. p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. Trends Mol Med 2009;15:531-41. [PMID: 19822456 DOI: 10.1016/j.molmed.2009.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
76 Lee HJ, Kim JM, Kim KH, Heo JI, Kwak SJ, Han JA. Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53. Cell Death Differ. 2015;22:86-95. [PMID: 25146923 DOI: 10.1038/cdd.2014.116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
77 Kim E, Giese A, Deppert W. Wild-type p53 in cancer cells: when a guardian turns into a blackguard. Biochem Pharmacol 2009;77:11-20. [PMID: 18812169 DOI: 10.1016/j.bcp.2008.08.030] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
78 Vousden KH. Partners in death: a role for p73 and NF-kB in promoting apoptosis. Aging (Albany NY) 2009;1:275-7. [PMID: 20157515 DOI: 10.18632/aging.100033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
79 Fan Y, Wang Y, Fu S, Liu D, Lin S. Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax. Exp Ther Med 2019;18:1563-70. [PMID: 31410110 DOI: 10.3892/etm.2019.7737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Ehrhardt H, Schrembs D, Moritz C, Wachter F, Haldar S, Graubner U, Nathrath M, Jeremias I. Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule. Blood 2011;118:6123-31. [PMID: 21926351 DOI: 10.1182/blood-2010-02-269811] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
81 Cheresh P, Kim SJ, Tulasiram S, Kamp DW. Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta 2013;1832:1028-40. [PMID: 23219955 DOI: 10.1016/j.bbadis.2012.11.021] [Cited by in Crossref: 215] [Cited by in F6Publishing: 201] [Article Influence: 21.5] [Reference Citation Analysis]
82 Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009;9:691-700. [PMID: 19759539 DOI: 10.1038/nrc2715] [Cited by in Crossref: 631] [Cited by in F6Publishing: 611] [Article Influence: 48.5] [Reference Citation Analysis]
83 Fan Y, Zhan Q, Xu H, Li L, Li C, Xiao Q, Xiang S, Hui T, Xiang T, Ren G. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway. Biochem Biophys Res Commun 2016;474:660-6. [PMID: 27150632 DOI: 10.1016/j.bbrc.2016.04.146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
84 Zhang C, Tsoi R, Wu F, You L. Processing Oscillatory Signals by Incoherent Feedforward Loops. PLoS Comput Biol 2016;12:e1005101. [PMID: 27623175 DOI: 10.1371/journal.pcbi.1005101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
85 Prieto González EA, Fuchs AG, Sánchez GS. Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes. Dose Response 2009;7:234-46. [PMID: 19809542 DOI: 10.2203/dose-response.08-026.Prieto] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 Liu G, Beri R, Mueller A, Kamp DW. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. Chem Biol Interact 2010;188:309-18. [PMID: 20380827 DOI: 10.1016/j.cbi.2010.03.047] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
87 N'guessan P, Pouyet L, Gosset G, Hamlaoui S, Seillier M, Cano CE, Seux M, Stocker P, Culcasi M, Iovanna JL, Dusetti NJ, Pietri S, Carrier A. Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis. Antioxid Redox Signal 2011;15:1639-53. [PMID: 21235351 DOI: 10.1089/ars.2010.3553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
88 Cooks T, Harris CC, Oren M. Caught in the cross fire: p53 in inflammation. Carcinogenesis 2014;35:1680-90. [PMID: 24942866 DOI: 10.1093/carcin/bgu134] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 11.6] [Reference Citation Analysis]
89 Kraljević Pavelić S, Marjanović M, Poznić M, Kralj M. Adenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment. J Cancer Res Clin Oncol 2009;135:1747-61. [PMID: 19548002 DOI: 10.1007/s00432-009-0621-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
90 Sermeus A, Michiels C. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis. 2011;2:e164. [PMID: 21614094 DOI: 10.1038/cddis.2011.48] [Cited by in Crossref: 174] [Cited by in F6Publishing: 167] [Article Influence: 15.8] [Reference Citation Analysis]
91 Kuppusamy P. Sense and Sensibility of Oxygen in Pathophysiology Using EPR Oximetry. In: Berliner LJ, Parinandi NL, editors. Measuring Oxidants and Oxidative Stress in Biological Systems. Cham: Springer International Publishing; 2020. pp. 135-87. [DOI: 10.1007/978-3-030-47318-1_9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Wickremasinghe RG, Prentice AG, Steele AJ. p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia 2011;25:1400-7. [PMID: 21566651 DOI: 10.1038/leu.2011.103] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
93 Zhou R, Xu A, Gingold J, Strong LC, Zhao R, Lee DF. Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. Trends Pharmacol Sci 2017;38:908-27. [PMID: 28818333 DOI: 10.1016/j.tips.2017.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
94 McClendon AK, Dean JL, Ertel A, Knudsen ES. Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model. PLoS One 2010;5:e8558. [PMID: 20049321 DOI: 10.1371/journal.pone.0008558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
95 Connell KA, Guess MK, Chen HW, Lynch T, Bercik R, Taylor HS. HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments. Reprod Sci 2009;16:694-700. [PMID: 19372592 DOI: 10.1177/1933719109334260] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
96 Zhang Y, Zhang Y, Zhao H, Zhai Q, Zhang Y, Shen Y. The impact of R213 mutation on p53-mediated p21 activity. Biochimie 2014;99:215-8. [DOI: 10.1016/j.biochi.2013.12.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
97 Shakya R, Tarulli GA, Sheng L, Lokman NA, Ricciardelli C, Pishas KI, Selinger CI, Kohonen-Corish MRJ, Cooper WA, Turner AG, Neilsen PM, Callen DF. Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer. Oncogene 2017;36:4469-80. [PMID: 28368395 DOI: 10.1038/onc.2017.66] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
98 Nguyen TL, Tumilasci VF, Singhroy D, Arguello M, Hiscott J. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies. Cell Microbiol 2009;11:889-97. [PMID: 19388908 DOI: 10.1111/j.1462-5822.2009.01317.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
99 Sung NY, Jeong D, Shim YY, Ratan ZA, Jang YJ, Reaney MJT, Lee S, Lee BH, Kim JH, Yi YS, Cho JY. The Anti-Cancer Effect of Linusorb B3 from Flaxseed Oil through the Promotion of Apoptosis, Inhibition of Actin Polymerization, and Suppression of Src Activity in Glioblastoma Cells. Molecules 2020;25:E5881. [PMID: 33322712 DOI: 10.3390/molecules25245881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 2009;11:2851-97. [PMID: 19432534 DOI: 10.1089/ars.2008.2412] [Cited by in Crossref: 283] [Cited by in F6Publishing: 263] [Article Influence: 21.8] [Reference Citation Analysis]
101 Kwon HK, Shin HJ, Lee JH, Park SH, Kwon MC, Panneerselvam S, Lee CG, Kim SG, Kim JH, Choi S. Etoposide Induces Necrosis Through p53-Mediated Antiapoptosis in Human Kidney Proximal Tubule Cells. Toxicol Sci 2015;148:204-19. [PMID: 26259609 DOI: 10.1093/toxsci/kfv182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
102 Koz ST, Etem EO, Baydas G, Yuce H, Ozercan HI, Kuloğlu T, Koz S, Etem A, Demir N. Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res 2012;1484:29-38. [PMID: 22995369 DOI: 10.1016/j.brainres.2012.09.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
103 Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009;137:413-31. [PMID: 19410540 DOI: 10.1016/j.cell.2009.04.037] [Cited by in Crossref: 1977] [Cited by in F6Publishing: 1959] [Article Influence: 152.1] [Reference Citation Analysis]
104 Yang W, Cai Q, Lui VW, Everley PA, Kim J, Bhola N, Quesnelle KM, Zetter BR, Steen H, Freeman MR. Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J Proteome Res. 2010;9:3073-3082. [PMID: 20426488 DOI: 10.1021/pr901211j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
105 Fabi F, Adam P, Vincent K, Demontigny F, Parent S, Joncas FH, Asselin E. Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death. Cell Commun Signal 2018;16:39. [PMID: 29973205 DOI: 10.1186/s12964-018-0252-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Shin Y, Lim H, Choi BS, Kim KC, Kang C, Bae YS, Yoon CH. Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs. Virol J 2016;13:141. [PMID: 27527606 DOI: 10.1186/s12985-016-0595-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
107 Zhu Y, Regunath K, Jacq X, Prives C. Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes Dev 2013;27:1739-51. [PMID: 23934659 DOI: 10.1101/gad.212258.112] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
108 Zhao J, Lu Y, Shen HM. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Lett 2012;314:8-23. [PMID: 22030255 DOI: 10.1016/j.canlet.2011.09.040] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
109 Wang YY, Xiao LY, Wu PC, Chen YK, Lo S, Hu SCS, Chen YH, Chiu CCC, Yuan SSF. Orabase-formulated gentian violet effectively improved oral potentially malignant disorder in vitro and in vivo. Biochem Pharmacol 2020;171:113713. [PMID: 31733192 DOI: 10.1016/j.bcp.2019.113713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Biswas S, Chen E, Haleyurgirisetty M, Lee S, Hewlett I, Devadas K. Comparison of miRNA Expression Profiles between HIV-1 and HIV-2 Infected Monocyte-Derived Macrophages (MDMs) and Peripheral Blood Mononuclear Cells (PBMCs). Int J Mol Sci. 2020;21:6970. [PMID: 32971935 DOI: 10.3390/ijms21186970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Sohn D, Peters D, Piekorz RP, Budach W, Jänicke RU. miR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1/CIP1 and caspase-3. Oncotarget 2016;7:15915-29. [PMID: 26895377 DOI: 10.18632/oncotarget.7432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
112 Cimica V, Smith ME, Zhang Z, Mathur D, Mani S, Kalpana GV. Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen. BMC Cancer 2010;10:634. [PMID: 21092078 DOI: 10.1186/1471-2407-10-634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
113 Tay CY, Fang W, Setyawati MI, Sum CP, Xie J, Ng KW, Chen X, Hong CHL, Leong DT. Reciprocal Response of Human Oral Epithelial Cells to Internalized Silica Nanoparticles. Part Part Syst Charact 2013;30:784-93. [DOI: 10.1002/ppsc.201300111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
114 Wachter F, Grunert M, Blaj C, Weinstock DM, Jeremias I, Ehrhardt H. Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling. Cell Commun Signal 2013;11:27. [PMID: 23594441 DOI: 10.1186/1478-811X-11-27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
115 Muller PA. NCF2/p67phox: A novel player in the anti-apoptotic functions of p53. Cell Cycle 2013;12:14. [PMID: 23255096 DOI: 10.4161/cc.23173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Cortes J, Kantarjian H, Ball ED, Dipersio J, Kolitz JE, Fernandez HF, Goodman M, Borthakur G, Baer MR, Wetzler M. Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer 2012;118:418-27. [PMID: 21717444 DOI: 10.1002/cncr.26292] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
117 Brigelius-flohé R, Flohé L. Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxidants & Redox Signaling 2020;33:498-516. [DOI: 10.1089/ars.2019.7905] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
118 Hochstenbach K, van Leeuwen DM, Gottschalk RW, Gmuender H, Stølevik SB, Nygaard UC, Løvik M, Granum B, Namork E, van Loveren H, van Delft JH. Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure. Mutat Res 2012;746:124-34. [PMID: 22269147 DOI: 10.1016/j.mrgentox.2012.01.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
119 Furth N, Aylon Y, Oren M. p53 shades of Hippo. Cell Death Differ 2018;25:81-92. [PMID: 28984872 DOI: 10.1038/cdd.2017.163] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]